Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial

OBJECTIVE: To confirm efficacy and safety of fast-acting insulin aspart (faster aspart) versus insulin aspart (IAsp), both with basal insulin degludec, in a pediatric population with type 1 diabetes. RESEARCH DESIGN AND METHODS: After a 12-week run-in, this treat-to-target, 26-week, multicenter tria...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Autores principales: Bode, Bruce W., Iotova, Violeta, Kovarenko, Margarita, Laffel, Lori M., Rao, Paturi V., Deenadayalan, Srikanth, Ekelund, Magnus, Larsen, Steffen Falgreen, Danne, Thomas
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2019
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973646/
https://ncbi.nlm.nih.gov/pubmed/31076415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-0009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares